CLINICAL_TRIALS
trial_result
· 2023-08-03
Clinical Trial Update: Safety and Efficacy of Emixustat in Stargardt Disease [Phase 3]
Summary
Phase 3 results report the safety and efficacy of Emixustat for Stargardt disease; the trial has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kubota Vision Inc. | Conditions: Stargardt Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-08-03